• Introduced
    May 04, 2026
  • Passed Assembly
    Jun 30, 2026
  • Passed Senate
    Jun 30, 2026
  • Became Law
    Jul 08, 2026
A 4852
New Jersey Assembly Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Last Action See all actions
executive • Jul 08, 2026: Approved P.L.2026, c.40.
Latest Bill Text See all bill texts

Summary

Comments on A 4852

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Jul 08, 2026 | executive
    • Approved P.L.2026, c.40.
  • Jun 30, 2026 | Senate
    • Received in the Senate without Reference, 2nd Reading
    • Substituted for S4194/4210 (SCS)
    • Passed Senate (Passed Both Houses) (38-2)
  • Jun 30, 2026 | Assembly
    • Passed by the Assembly (76-2-1)
  • Jun 23, 2026 | Assembly
    • Transferred to Assembly State and Local Government Committee
    • Reported from Assembly Comm. as a Substitute, 2nd Reading
  • May 04, 2026 | Assembly
    • Introduced, Referred to Assembly Health Committee